Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Original NDA and Original BLA Approvals
February 1970

This report includes NDAs [including NDAs for new molecular entities (NMEs)] and BLAs (including new biological products) approved for the first time during the selected month. Original BLA/NDA approvals by CBER are not included in Drugs@FDA. This report does not include approved NDA or BLA supplements, approved ANDAs, or tentatively approved ANDAs/NDAs.

Click on the Drug Name and Application Number to see information about the drug (for example, regulatory history, labeling, reviews by FDA staff).

This report was produced on October 17, 2021.

Approval Date Drug Name Active Ingredients Submission Classification * Review Priority ** Company
02/19/1970 KETALAR
NDA #016812
KETAMINE HYDROCHLORIDE Type 1 - New Molecular Entity Priority PAR STERILE PRODUCTS
02/22/1970 CLEOCIN HYDROCHLORIDE
NDA #050162
CLINDAMYCIN HYDROCHLORIDE Unknown PFIZER
02/27/1970 SERENTIL
NDA #016774
MESORIDAZINE BESYLATE Type 1 - New Molecular Entity Standard NOVARTIS
02/27/1970 SERENTIL
NDA #016775
MESORIDAZINE BESYLATE Type 3 - New Dosage Form Standard NOVARTIS

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English